THRX

Theseus Pharmaceuticals, Inc.CIK 1745020 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for THRX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for THRX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Dahms Bradford D.	President and CFO	8	$30.0K	$0	2024-02-14
Yi Kathy	Director	6	$0	$0	2024-02-14
Dukes Iain D.	Director	10	$0	$0	2024-02-14
Stein Steven H	Director	4	$0	$0	2024-02-14
GORDON CARL L	Director, 10% Owner	24	$14.49M	$0	2024-02-14
HAYDEN DONALD J JR	Director	7	$50.0K	$0	2024-02-14
ORBIMED ADVISORS LLC	Director, 10% Owner	4	$1.46M	$0	2024-02-14
Shakespeare William	See Remarks	6	$10.0K	$0	2023-11-06
Foresite Capital Opportunity Management V, LLC	10% Owner	4	$4.58M	$0	2023-07-17
Rivera Victor	Chief Scientific Officer	3	$0	$0	2023-03-01
Kerstein David	Chief Medical Officer	3	$0	$0	2023-03-01
CLACKSON TIMOTHY P	President and CEO	5	$42.4K	$0	2023-03-01
OrbiMed Genesis GP LLC	Director, 10% Owner	8	$11.00M	$0	2022-11-07
Dalgarno David	Chief Technical Officer	1	$0	$0	2022-02-18
OrbiMed Capital GP VII LLC	Director, 10% Owner	7	$2.02M	$0	2022-01-21
Rock Springs Capital LLC	10% Owner	5	$4.00M	$0	2021-10-12
Paster Anne-Mari	Other	3	$3.00M	$0	2021-10-12
TAKEDA PHARMACEUTICAL CO LTD	10% Owner	2	$0	$0	2021-10-12
dEsparbes Eric	SVP and CFO	3	$0	$0	2015-11-20
GLAXOSMITHKLINE PLC	10% Owner	15	$366312.37B	$0	2015-08-07
Faerm Michael E.	Sr VP & Chief Business Officer	1	$0	$0	2015-07-23
Tyree James L	Director	11	$0	$41.1K	2015-06-02
Aguiar Michael W	Sr VP, Chief Financial Officer	35	$0	$8.52M	2015-06-02
WALTRIP WILLIAM H	Director	14	$0	$266.2K	2015-05-27
PEPE PAUL	Director	10	$0	$0	2015-04-24
FRIEDMAN CATHY	Director	10	$0	$0	2015-04-24
Kearney Terrence C	Director	2	$0	$0	2015-04-24
WITEK THEODORE L JR	Sr. VP, Corp Partnerships	3	$0	$0	2015-01-07
ABERCROMBIE GEORGE B	Sr. VP, Corp. Partnerships	3	$0	$0	2015-01-07
LEE JUNNING	Sr. VP, Technical Operations	17	$0	$1.20M	2014-08-20
Mammen Mathai	SVP, Research & Early Clin Dev	47	$0	$2.82M	2014-08-20
Shafer Bradford J	Sr VP, Gen. Counsel, Secretary	31	$0	$4.13M	2014-08-20
BLUM LEONARD M	Sr VP, Chief Comm. Officer	13	$0	$0	2014-08-20
Winningham Rick E	Director	33	$0	$11.61M	2014-08-15
Fore Henrietta	Director	6	$0	$0	2014-05-22
Gunderson Robert V JR	Director	8	$0	$0	2014-05-22
WHITESIDES GEORGE M	Director	8	$0	$0	2014-05-22
YOUNG WILLIAM D	Director	8	$0	$0	2014-05-22
RINGROSE PETER S	Director	6	$0	$0	2014-05-22
MALKIEL BURTON G	Director	7	$0	$0	2014-05-22
LEVINE ARNOLD J	Director	6	$0	$0	2014-03-21
PASQUALONE FRANK	Sr. Vice President, Operations	2	$0	$0	2014-01-23
JONKER JEFFREY DAVID	Senior VP, Corp. & Bus. Dev.	2	$0	$0	2013-10-22
Brinkley David L	Head of Business Dev.	26	$0	$5.48M	2013-05-29
DRAZAN JEFFREY M	Director	1	$0	$186.4K	2012-05-01

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Dahms Bradford D.	President and CFO	D To issuer deriv	2024-02-14	2024-02-14	17,500	—	$0	0	SEC↗
Dahms Bradford D.	President and CFO	D To issuer deriv	2024-02-14	2024-02-14	332,114	—	$0	0	SEC↗
Dukes Iain D.	Director	D To issuer deriv	2024-02-14	2024-02-14	3,250	—	$0	0	SEC↗
Dukes Iain D.	Director	D To issuer deriv	2024-02-14	2024-02-14	344,344	—	$0	0	SEC↗
Dukes Iain D.	Director	D To issuer deriv	2024-02-14	2024-02-14	61,549	—	$0	0	SEC↗
Dukes Iain D.	Director	D To issuer deriv	2024-02-14	2024-02-14	36,066	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	D To issuer deriv	2024-02-14	2024-02-14	3,250	—	$0	0	SEC↗
HAYDEN DONALD J JR	Director	D To issuer deriv	2024-02-14	2024-02-14	3,250	—	$0	0	SEC↗
Stein Steven H	Director	D To issuer deriv	2024-02-14	2024-02-14	3,250	—	$0	0	SEC↗
Yi Kathy	Director	D To issuer deriv	2024-02-14	2024-02-14	99,634	—	$0	0	SEC↗
Yi Kathy	Director	D To issuer deriv	2024-02-14	2024-02-14	3,250	—	$0	0	SEC↗
Dahms Bradford D.	President and CFO	U Tender	2024-02-14	2024-02-14	8,150	—	$0	0	SEC↗
Dukes Iain D.	Director	U Tender	2024-02-14	2024-02-14	388,324	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	U Tender	2024-02-14	2024-02-14	650,600	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	U Tender	2024-02-14	2024-02-14	17,063,000	—	$0	0	SEC↗
HAYDEN DONALD J JR	Director	U Tender	2024-02-14	2024-02-14	10,000	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	U Tender	2024-02-14	2024-02-14	17,063,000	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	U Tender	2024-02-14	2024-02-14	650,600	—	$0	0	SEC↗
Shakespeare William	See Remarks	M Exercise deriv	2023-11-06	2023-11-07	251,084	—	$0	93,260	SEC↗
Shakespeare William	See Remarks	M Exercise	2023-11-06	2023-11-07	251,084	$0.32	$80.3K	639,408	SEC↗
Foresite Capital Opportunity M	10% Owner	P Buy	2023-07-17	2023-07-19	523,450	$2.97	$1.55M	4,108,796	SEC↗
Foresite Capital Opportunity M	10% Owner	P Buy	2023-07-17	2023-07-19	176,550	$2.97	$524.4K	1,385,825	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2023-07-17	2023-07-19	151,450	$3.05	$461.9K	650,600	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2023-07-17	2023-07-19	328,482	$3.05	$1.00M	17,063,000	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2023-07-17	2023-07-19	328,482	$3.05	$1.00M	17,063,000	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2023-07-17	2023-07-19	151,450	$3.05	$461.9K	650,600	SEC↗
Dukes Iain D.	Director	A Award deriv	2023-06-13	2023-06-13	3,250	—	$0	3,250	SEC↗
Dukes Iain D.	Director	A Award deriv	2023-06-13	2023-06-13	19,500	—	$0	19,500	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2023-06-13	2023-06-13	3,250	—	$0	3,250	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2023-06-13	2023-06-13	19,500	—	$0	19,500	SEC↗
HAYDEN DONALD J JR	Director	A Award deriv	2023-06-13	2023-06-13	3,250	—	$0	3,250	SEC↗
HAYDEN DONALD J JR	Director	A Award deriv	2023-06-13	2023-06-13	19,500	—	$0	19,500	SEC↗
Yi Kathy	Director	A Award deriv	2023-06-13	2023-06-13	19,500	—	$0	19,500	SEC↗
Yi Kathy	Director	A Award deriv	2023-06-13	2023-06-13	3,250	—	$0	3,250	SEC↗
Stein Steven H	Director	A Award deriv	2023-06-13	2023-06-13	3,250	—	$0	3,250	SEC↗
Stein Steven H	Director	A Award deriv	2023-06-13	2023-06-13	19,500	—	$0	19,500	SEC↗
CLACKSON TIMOTHY P	President and CEO	A Award deriv	2023-03-01	2023-03-02	45,625	—	$0	45,625	SEC↗
Dahms Bradford D.	Chief Financial Officer	A Award deriv	2023-03-01	2023-03-02	17,500	—	$0	17,500	SEC↗
Kerstein David	Chief Medical Officer	A Award deriv	2023-03-01	2023-03-02	17,500	—	$0	17,500	SEC↗
Shakespeare William	See Remarks	A Award deriv	2023-03-01	2023-03-02	21,250	—	$0	21,250	SEC↗
Rivera Victor	Chief Scientific Officer	A Award deriv	2023-03-01	2023-03-02	16,250	—	$0	16,250	SEC↗
CLACKSON TIMOTHY P	President and CEO	A Award deriv	2023-02-17	2023-02-21	273,750	—	$0	273,750	SEC↗
Dahms Bradford D.	Chief Financial Officer	A Award deriv	2023-02-17	2023-02-21	105,000	—	$0	105,000	SEC↗
Kerstein David	Chief Medical Officer	A Award deriv	2023-02-17	2023-02-21	105,000	—	$0	105,000	SEC↗
Rivera Victor	Chief Scientific Officer	A Award deriv	2023-02-17	2023-02-21	97,500	—	$0	97,500	SEC↗
Shakespeare William	See Remarks	A Award deriv	2023-02-17	2023-02-21	127,500	—	$0	127,500	SEC↗
HAYDEN DONALD J JR	Director	P Buy	2022-12-30	2023-01-03	9,900	$5.00	$49.5K	10,000	SEC↗
HAYDEN DONALD J JR	Director	P Buy	2022-12-29	2023-01-03	100	$5.00	$500	100	SEC↗
Foresite Capital Opportunity M	10% Owner	P Buy	2022-12-29	2023-01-03	250,000	$5.00	$1.25M	1,209,275	SEC↗
Foresite Capital Opportunity M	10% Owner	P Buy	2022-12-29	2023-01-03	250,000	$5.00	$1.25M	3,585,346	SEC↗
Dahms Bradford D.	Chief Financial Officer	P Buy	2022-11-30	2022-12-01	1,502	$6.66	$10.0K	6,142	SEC↗
CLACKSON TIMOTHY P	President and CEO	P Buy	2022-11-11	2022-11-14	2,500	$6.80	$17.0K	351,030	SEC↗
OrbiMed Genesis GP LLC	Director, 10% Owner	P Buy	2022-11-07	2022-11-09	192,000	$5.21	$1.00M	16,734,518	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-11-07	2022-11-09	192,000	$5.21	$1.00M	16,734,518	SEC↗
Stein Steven H	Director	A Award deriv	2022-10-17	2022-10-19	60,000	—	$0	60,000	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2022-06-10	2022-06-13	30,000	—	$0	30,000	SEC↗
Dukes Iain D.	Chairman	A Award deriv	2022-06-10	2022-06-13	15,000	—	$0	15,000	SEC↗
Dukes Iain D.	Chairman	A Award deriv	2022-06-10	2022-06-13	30,000	—	$0	30,000	SEC↗
Yi Kathy	Director	A Award deriv	2022-06-10	2022-06-13	30,000	—	$0	30,000	SEC↗
HAYDEN DONALD J JR	Director	A Award deriv	2022-05-17	2022-05-18	60,000	—	$0	60,000	SEC↗
Rivera Victor	Chief Scientific Officer	A Award deriv	2022-02-18	2022-02-23	130,000	—	$0	130,000	SEC↗
Shakespeare William	See Remarks	A Award deriv	2022-02-18	2022-02-23	180,000	—	$0	180,000	SEC↗
Dahms Bradford D.	Chief Financial Officer	A Award deriv	2022-02-18	2022-02-23	150,000	—	$0	150,000	SEC↗
Dalgarno David	Chief Technical Officer	A Award deriv	2022-02-18	2022-02-23	130,000	—	$0	130,000	SEC↗
CLACKSON TIMOTHY P	President and CEO	A Award deriv	2022-02-18	2022-02-23	450,000	—	$0	450,000	SEC↗
Kerstein David	Chief Medical Officer	A Award deriv	2022-02-18	2022-02-23	150,000	—	$0	150,000	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy	2022-01-21	2022-01-21	111,896	$9.97	$1.12M	16,542,652	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-01-21	2022-01-21	111,896	$9.97	$1.12M	16,542,652	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy	2022-01-20	2022-01-21	35,000	$9.95	$348.3K	16,430,756	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-01-20	2022-01-21	35,000	$9.95	$348.3K	16,430,756	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy	2022-01-19	2022-01-21	11,521	$9.97	$114.9K	16,395,756	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-01-19	2022-01-21	11,521	$9.97	$114.9K	16,395,756	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy	2022-01-13	2022-01-13	17,320	$9.43	$163.3K	16,384,235	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-01-13	2022-01-13	17,320	$9.43	$163.3K	16,384,235	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy	2022-01-12	2022-01-13	18,897	$10.06	$190.1K	16,366,915	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-01-12	2022-01-13	18,897	$10.06	$190.1K	16,366,915	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy	2022-01-11	2022-01-13	1,600	$9.81	$15.7K	16,341,118	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy	2022-01-11	2022-01-13	6,900	$10.67	$73.6K	16,348,018	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-01-11	2022-01-13	6,900	$10.67	$73.6K	16,348,018	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-01-11	2022-01-13	1,600	$9.81	$15.7K	16,341,118	SEC↗
Dahms Bradford D.	Chief Financial Officer	P Buy	2021-12-21	2021-12-22	1,970	$10.15	$20.0K	1,970	SEC↗
CLACKSON TIMOTHY P	President and CEO	P Buy	2021-12-21	2021-12-22	2,600	$9.76	$25.4K	348,530	SEC↗
Paster Anne-Mari	Other	C Conversion deriv	2021-10-12	2021-10-14	693,152	—	$0	0	SEC↗
OrbiMed Genesis GP LLC	10% Owner	C Conversion deriv	2021-10-12	2021-10-14	14,903,718	—	$0	0	SEC↗
OrbiMed Genesis GP LLC	10% Owner	C Conversion deriv	2021-10-12	2021-10-14	436,650	—	$0	0	SEC↗
OrbiMed Genesis GP LLC	10% Owner	C Conversion deriv	2021-10-12	2021-10-14	873,300	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion deriv	2021-10-12	2021-10-14	873,300	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion deriv	2021-10-12	2021-10-14	436,650	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion deriv	2021-10-12	2021-10-14	14,903,718	—	$0	0	SEC↗
Rock Springs Capital LLC	10% Owner	C Conversion deriv	2021-10-12	2021-10-14	349,320	—	$0	0	SEC↗
Rock Springs Capital LLC	10% Owner	C Conversion deriv	2021-10-12	2021-10-14	87,329	—	$0	0	SEC↗
TAKEDA PHARMACEUTICAL CO LTD	10% Owner	C Conversion deriv	2021-10-12	2021-10-15	1,615,427	—	$0	0	SEC↗
Paster Anne-Mari	Other	C Conversion	2021-10-12	2021-10-14	523,979	—	$0	523,979	SEC↗
Paster Anne-Mari	Other	P Buy	2021-10-12	2021-10-14	187,500	$16.00	$3.00M	711,479	SEC↗
Shakespeare William	See Remarks	P Buy	2021-10-12	2021-10-14	625	$16.00	$10.0K	388,949	SEC↗
OrbiMed Genesis GP LLC	10% Owner	P Buy	2021-10-12	2021-10-14	62,500	$16.00	$1.00M	499,150	SEC↗
OrbiMed Genesis GP LLC	10% Owner	P Buy	2021-10-12	2021-10-14	562,500	$16.00	$9.00M	16,339,518	SEC↗
OrbiMed Genesis GP LLC	10% Owner	C Conversion	2021-10-12	2021-10-14	436,650	—	$0	436,650	SEC↗
OrbiMed Genesis GP LLC	10% Owner	C Conversion	2021-10-12	2021-10-14	15,777,018	—	$0	15,777,018	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion	2021-10-12	2021-10-14	15,777,018	—	$0	15,777,018	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion	2021-10-12	2021-10-14	436,650	—	$0	436,650	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2021-10-12	2021-10-14	562,500	$16.00	$9.00M	16,339,518	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2021-10-12	2021-10-14	62,500	$16.00	$1.00M	499,150	SEC↗
Rock Springs Capital LLC	10% Owner	C Conversion	2021-10-12	2021-10-14	349,320	—	$0	349,320	SEC↗
Rock Springs Capital LLC	10% Owner	C Conversion	2021-10-12	2021-10-14	87,329	—	$0	87,329	SEC↗
Rock Springs Capital LLC	10% Owner	P Buy	2021-10-12	2021-10-14	250,000	$16.00	$4.00M	599,320	SEC↗
TAKEDA PHARMACEUTICAL CO LTD	10% Owner	C Conversion	2021-10-12	2021-10-15	1,615,427	—	$0	1,615,427	SEC↗
Yi Kathy	Director	A Award deriv	2021-10-06	2021-10-08	22,678	—	$0	22,678	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2021-10-06	2021-10-08	22,678	—	$0	22,678	SEC↗
Dukes Iain D.	Director	A Award deriv	2021-10-06	2021-10-08	22,678	—	$0	22,678	SEC↗
dEsparbes Eric	SVP and CFO	F Tax w/h	2015-11-20	2015-11-23	7,940	$8.92	$70.8K	132,779	SEC↗
GLAXOSMITHKLINE PLC	10% Owner	P Buy	2015-08-07	2015-08-07	245,828	$3485841.04	$856.92B	32,005,260	SEC↗
Faerm Michael E.	Sr VP & Chief Business Offic	A Award	2015-07-23	2015-07-27	105,288	—	$0	105,288	SEC↗
Tyree James L	Director	S Sale	2015-06-02	2015-06-04	2,438	$16.85	$41.1K	33,182	SEC↗
Aguiar Michael W	President & CEO	F Tax w/h	2015-06-02	2015-06-04	24,698	$16.68	$412.0K	432,653	SEC↗
WALTRIP WILLIAM H	Director	M Exercise deriv	2015-05-27	2015-05-29	16,313	—	$0	0	SEC↗
WALTRIP WILLIAM H	Director	M Exercise	2015-05-27	2015-05-29	16,313	$13.45	$219.4K	139,917	SEC↗
WALTRIP WILLIAM H	Director	S Sale	2015-05-27	2015-05-29	16,313	$16.32	$266.2K	123,604	SEC↗
Aguiar Michael W	President & CEO	F Tax w/h	2015-05-20	2015-05-22	3,256	$16.24	$52.9K	457,351	SEC↗
GLAXOSMITHKLINE PLC	10% Owner	P Buy	2015-05-11	2015-05-11	85,579	$1369264.00	$117.18B	31,759,432	SEC↗
Tyree James L	Director	A Award	2015-04-24	2015-04-27	13,950	—	$0	35,620	SEC↗
PEPE PAUL	Director	A Award	2015-04-24	2015-04-27	13,950	—	$0	35,620	SEC↗
FRIEDMAN CATHY	Director	A Award	2015-04-24	2015-04-27	13,950	—	$0	35,620	SEC↗
Kearney Terrence C	Director	A Award	2015-04-24	2015-04-27	13,950	—	$0	37,083	SEC↗
WALTRIP WILLIAM H	Director	A Award	2015-04-24	2015-04-27	13,950	—	$0	117,264	SEC↗
WALTRIP WILLIAM H	Director	A Award	2015-04-24	2015-05-29	13,950	—	$0	123,604	SEC↗
GLAXOSMITHKLINE PLC	10% Owner	P Buy	2015-03-02	2015-03-02	92,674	$1673692.44	$155.11B	31,673,853	SEC↗
Aguiar Michael W	President & CEO	F Tax w/h	2015-02-20	2015-05-22	6,789	$18.22	$123.7K	458,107	SEC↗
Aguiar Michael W	President & CEO	F Tax w/h	2015-02-20	2015-02-24	6,789	$18.22	$123.7K	446,148	SEC↗
dEsparbes Eric	SVP and CFO	A Award	2015-01-07	2015-01-09	36,972	—	$0	139,443	SEC↗
Aguiar Michael W	President & CEO	A Award	2015-01-07	2015-01-09	176,056	—	$0	464,896	SEC↗
ABERCROMBIE GEORGE B	Sr. VP, Corp. Partnerships	A Award	2015-01-07	2015-01-09	71,429	—	$0	81,429	SEC↗
WITEK THEODORE L JR	Sr. VP, Corp Partnerships	A Award	2015-01-07	2015-01-09	71,429	—	$0	71,429	SEC↗
WITEK THEODORE L JR	Sr. VP, Corp Partnerships	A Award	2015-01-07	2015-02-23	71,429	—	$0	71,429	SEC↗
FRIEDMAN CATHY	Director	A Award	2014-12-22	2014-12-23	6,500	—	$0	21,670	SEC↗
WALTRIP WILLIAM H	Director	A Award	2014-12-22	2014-12-23	3,250	—	$0	103,314	SEC↗
PEPE PAUL	Director	A Award	2014-12-22	2014-12-23	6,500	—	$0	21,670	SEC↗
Tyree James L	Director	A Award	2014-12-22	2014-12-23	6,500	—	$0	21,670	SEC↗
GLAXOSMITHKLINE PLC	10% Owner	P Buy	2014-11-04	2014-11-04	832,456	$12786524.16	$10644.22B	31,581,179	SEC↗
Kearney Terrence C	Director	A Award	2014-10-30	2014-11-03	23,133	—	$0	23,133	SEC↗
dEsparbes Eric	SVP and CFO	A Award	2014-10-16	2014-10-17	102,471	—	$0	102,471	SEC↗
BLUM LEONARD M	Sr VP, Chief Comm. Officer	F Tax w/h	2014-08-20	2014-08-22	3,261	$22.76	$74.2K	401,538	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	F Tax w/h	2014-08-20	2014-08-22	3,261	$22.76	$74.2K	443,013	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	F Tax w/h	2014-08-20	2014-08-22	3,261	$22.76	$74.2K	334,040	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	F Tax w/h	2014-08-20	2014-08-22	3,261	$22.76	$74.2K	262,198	SEC↗
Aguiar Michael W	President & CEO	A Award	2014-08-15	2014-08-19	43,905	—	$0	288,840	SEC↗
Winningham Rick E	Director	D To issuer	2014-08-15	2014-08-19	96,250	—	$0	825,391	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	M Exercise deriv	2014-08-13	2014-08-15	12,516	—	$0	0	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	M Exercise deriv	2014-08-13	2014-08-15	24,338	—	$0	0	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	M Exercise deriv	2014-08-13	2014-08-15	23,705	—	$0	0	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	M Exercise deriv	2014-08-13	2014-08-15	13,882	—	$0	0	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	M Exercise	2014-08-13	2014-08-15	12,516	$14.53	$181.9K	270,840	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	M Exercise	2014-08-13	2014-08-15	13,882	$9.81	$136.2K	258,324	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	M Exercise	2014-08-13	2014-08-15	23,705	$12.66	$300.1K	318,883	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	M Exercise	2014-08-13	2014-08-15	24,338	$12.66	$308.1K	295,178	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	S Sale	2014-08-13	2014-08-15	53,424	$22.50	$1.20M	265,459	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	S Sale	2014-08-12	2014-08-13	1,048	$22.30	$23.4K	446,274	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	M Exercise deriv	2014-08-11	2014-08-13	33,667	$14.53	$489.2K	0	SEC↗
GLAXOSMITHKLINE PLC	10% Owner	P Buy	2014-08-11	2014-08-11	172,651	$3912271.66	$675.46B	30,748,723	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	S Sale	2014-08-11	2014-08-13	27,108	$22.12	$599.6K	447,322	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	M Exercise	2014-08-11	2014-08-13	33,667	$14.53	$489.2K	474,430	SEC↗
WITEK THEODORE L JR	Sr. VP, Corp Partnerships	A Award deriv	2014-07-24	2014-07-28	125,000	—	$0	125,000	SEC↗
ABERCROMBIE GEORGE B	Sr. VP, Corp. Partnerships	A Award deriv	2014-06-19	2014-06-23	100,000	—	$0	100,000	SEC↗
ABERCROMBIE GEORGE B	Sr. VP, Corp. Partnerships	A Award	2014-06-19	2014-06-23	10,000	—	$0	10,000	SEC↗
Aguiar Michael W	Sr VP, Chief Financial Offic	A Award	2014-06-16	2014-06-18	28,365	—	$0	244,935	SEC↗
BLUM LEONARD M	Sr VP, Chief Comm. Officer	A Award	2014-06-16	2014-06-18	28,365	—	$0	404,799	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	A Award	2014-06-16	2014-06-18	19,855	—	$0	244,442	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	A Award	2014-06-16	2014-06-18	28,365	—	$0	337,301	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	A Award	2014-06-16	2014-06-18	28,365	—	$0	440,763	SEC↗
Winningham Rick E	Chief Executive Officer	A Award	2014-06-16	2014-06-18	62,403	—	$0	921,641	SEC↗
FRIEDMAN CATHY	Director	A Award deriv	2014-06-02	2014-06-04	6,000	—	$0	6,000	SEC↗
FRIEDMAN CATHY	Director	A Award deriv	2014-06-02	2014-06-04	6,000	—	$0	6,000	SEC↗
PEPE PAUL	Director	A Award deriv	2014-06-02	2014-06-04	6,000	—	$0	6,000	SEC↗
PEPE PAUL	Director	A Award deriv	2014-06-02	2014-06-04	6,000	—	$0	6,000	SEC↗
Tyree James L	Director	A Award deriv	2014-06-02	2014-06-04	6,000	—	$0	6,000	SEC↗
Tyree James L	Director	A Award deriv	2014-06-02	2014-06-04	6,000	—	$0	6,000	SEC↗
FRIEDMAN CATHY	Director	A Award deriv	2014-06-02	2014-06-09	7,585	—	$0	7,585	SEC↗
FRIEDMAN CATHY	Director	A Award deriv	2014-06-02	2014-06-09	7,585	—	$0	7,585	SEC↗
PEPE PAUL	Director	A Award deriv	2014-06-02	2014-06-09	7,585	—	$0	7,585	SEC↗
PEPE PAUL	Director	A Award deriv	2014-06-02	2014-06-09	7,585	—	$0	7,585	SEC↗
Tyree James L	Director	A Award deriv	2014-06-02	2014-06-09	7,585	—	$0	7,585	SEC↗
Tyree James L	Director	A Award deriv	2014-06-02	2014-06-09	7,585	—	$0	7,585	SEC↗
Aguiar Michael W	Sr VP, Chief Financial Offic	A Award	2014-06-02	2014-06-04	50,000	—	$0	195,570	SEC↗
Aguiar Michael W	Sr VP, Chief Financial Offic	A Award	2014-06-02	2014-06-04	21,000	—	$0	216,570	SEC↗
BLUM LEONARD M	Sr VP, Chief Comm. Officer	A Award	2014-06-02	2014-06-04	21,000	—	$0	376,434	SEC↗
BLUM LEONARD M	Sr VP, Chief Comm. Officer	A Award	2014-06-02	2014-06-04	50,000	—	$0	355,434	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	A Award	2014-06-02	2014-06-04	50,000	—	$0	209,887	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	A Award	2014-06-02	2014-06-04	14,700	—	$0	224,587	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	A Award	2014-06-02	2014-06-04	50,000	—	$0	287,936	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	A Award	2014-06-02	2014-06-04	21,000	—	$0	308,936	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	A Award	2014-06-02	2014-06-04	50,000	—	$0	391,398	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	A Award	2014-06-02	2014-06-04	21,000	—	$0	412,398	SEC↗
Winningham Rick E	Chief Executive Officer	A Award	2014-06-02	2014-06-04	110,000	—	$0	813,038	SEC↗
Winningham Rick E	Chief Executive Officer	A Award	2014-06-02	2014-06-04	46,200	—	$0	859,238	SEC↗
FRIEDMAN CATHY	Director	A Award	2014-06-02	2014-06-04	6,000	—	$0	6,000	SEC↗
FRIEDMAN CATHY	Director	A Award	2014-06-02	2014-06-04	6,000	—	$0	12,000	SEC↗
PEPE PAUL	Director	A Award	2014-06-02	2014-06-04	6,000	—	$0	6,000	SEC↗
PEPE PAUL	Director	A Award	2014-06-02	2014-06-04	6,000	—	$0	12,000	SEC↗
Tyree James L	Director	A Award	2014-06-02	2014-06-04	6,000	—	$0	6,000	SEC↗
Tyree James L	Director	A Award	2014-06-02	2014-06-04	6,000	—	$0	12,000	SEC↗
FRIEDMAN CATHY	Director	A Award	2014-06-02	2014-06-09	7,585	—	$0	15,170	SEC↗
FRIEDMAN CATHY	Director	A Award	2014-06-02	2014-06-09	7,585	—	$0	7,585	SEC↗
PEPE PAUL	Director	A Award	2014-06-02	2014-06-09	7,585	—	$0	15,170	SEC↗
PEPE PAUL	Director	A Award	2014-06-02	2014-06-09	7,585	—	$0	7,585	SEC↗
Tyree James L	Director	A Award	2014-06-02	2014-06-09	7,585	—	$0	15,170	SEC↗
Tyree James L	Director	A Award	2014-06-02	2014-06-09	7,585	—	$0	7,585	SEC↗
Fore Henrietta	Director	A Award deriv	2014-05-22	2014-05-27	6,000	—	$0	6,000	SEC↗
Gunderson Robert V JR	Director	A Award deriv	2014-05-22	2014-05-27	6,000	—	$0	6,000	SEC↗
MALKIEL BURTON G	Director	A Award deriv	2014-05-22	2014-05-27	6,000	—	$0	6,000	SEC↗
RINGROSE PETER S	Director	A Award deriv	2014-05-22	2014-05-27	6,000	—	$0	6,000	SEC↗
WALTRIP WILLIAM H	Director	A Award deriv	2014-05-22	2014-05-27	6,000	—	$0	6,000	SEC↗
WHITESIDES GEORGE M	Director	A Award deriv	2014-05-22	2014-05-27	6,000	—	$0	6,000	SEC↗
YOUNG WILLIAM D	Director	A Award deriv	2014-05-22	2014-05-27	6,000	—	$0	6,000	SEC↗
Fore Henrietta	Director	A Award	2014-05-22	2014-05-27	6,000	—	$0	33,000	SEC↗
Gunderson Robert V JR	Director	A Award	2014-05-22	2014-05-27	6,000	—	$0	115,970	SEC↗
MALKIEL BURTON G	Director	A Award	2014-05-22	2014-05-27	6,000	—	$0	41,000	SEC↗
RINGROSE PETER S	Director	A Award	2014-05-22	2014-05-27	6,000	—	$0	36,000	SEC↗
WALTRIP WILLIAM H	Director	A Award	2014-05-22	2014-05-27	6,000	—	$0	100,064	SEC↗
WHITESIDES GEORGE M	Director	A Award	2014-05-22	2014-05-27	6,000	—	$0	606,377	SEC↗
YOUNG WILLIAM D	Director	A Award	2014-05-22	2014-05-27	6,000	—	$0	83,935	SEC↗
Aguiar Michael W	Sr VP, Chief Financial Offic	F Tax w/h	2014-05-09	2014-05-12	21,405	$26.86	$574.9K	145,570	SEC↗
BLUM LEONARD M	Sr VP, Chief Comm. Officer	F Tax w/h	2014-05-09	2014-05-12	18,849	$26.86	$506.3K	305,434	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	F Tax w/h	2014-05-09	2014-05-12	14,650	$26.86	$393.5K	159,887	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	F Tax w/h	2014-05-09	2014-05-12	22,833	$26.86	$613.3K	239,136	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	F Tax w/h	2014-05-09	2014-05-12	22,833	$26.86	$613.3K	341,398	SEC↗
Winningham Rick E	Chief Executive Officer	F Tax w/h	2014-05-09	2014-05-12	50,225	$26.86	$1.35M	703,038	SEC↗
GLAXOSMITHKLINE PLC	10% Owner	P Buy	2014-05-09	2014-05-13	317,770	$8544835.30	$2715.29B	30,576,072	SEC↗
Aguiar Michael W	Sr VP, Chief Financial Offic	A Award	2014-04-27	2014-04-29	37,500	—	$0	166,975	SEC↗
BLUM LEONARD M	Sr VP, Chief Comm. Officer	A Award	2014-04-27	2014-04-29	37,500	—	$0	324,283	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	A Award	2014-04-27	2014-04-29	26,250	—	$0	174,537	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	A Award	2014-04-27	2014-04-29	37,500	—	$0	261,969	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	A Award	2014-04-27	2014-04-29	37,500	—	$0	364,231	SEC↗
Winningham Rick E	Chief Executive Officer	A Award	2014-04-27	2014-04-29	82,500	—	$0	753,263	SEC↗
Gunderson Robert V JR	Director	M Exercise deriv	2014-04-17	2014-04-21	25,806	—	$0	0	SEC↗
Gunderson Robert V JR	Director	M Exercise	2014-04-17	2014-04-21	25,806	$9.69	$250.1K	109,970	SEC↗
YOUNG WILLIAM D	Director	M Exercise deriv	2014-04-07	2014-04-09	25,806	—	$0	0	SEC↗
YOUNG WILLIAM D	Director	M Exercise	2014-04-07	2014-04-09	25,806	$9.69	$250.1K	77,935	SEC↗
WALTRIP WILLIAM H	Director	M Exercise deriv	2014-03-31	2014-04-02	25,806	—	$0	0	SEC↗
WALTRIP WILLIAM H	Director	M Exercise	2014-03-31	2014-04-02	25,806	$9.69	$250.1K	94,064	SEC↗
LEVINE ARNOLD J	Director	M Exercise deriv	2014-03-21	2014-03-25	25,806	—	$0	0	SEC↗
LEVINE ARNOLD J	Director	M Exercise	2014-03-21	2014-03-25	25,806	$9.69	$250.1K	111,794	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	G Gift	2014-03-13	2014-05-12	1,200	—	$0	237,936	SEC↗
WHITESIDES GEORGE M	Director	M Exercise deriv	2014-03-06	2014-03-10	25,806	—	$0	0	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	M Exercise deriv	2014-03-06	2014-03-10	12,903	—	$0	0	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	M Exercise deriv	2014-03-06	2014-03-10	29,250	—	$0	0	SEC↗
WHITESIDES GEORGE M	Director	M Exercise	2014-03-06	2014-03-10	25,806	$9.69	$250.1K	600,377	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	M Exercise	2014-03-06	2014-03-10	12,903	$12.40	$160.0K	195,219	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	M Exercise	2014-03-06	2014-03-10	29,250	$16.00	$468.0K	224,469	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	M Exercise deriv	2014-03-03	2014-03-05	65,806	—	$0	0	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	M Exercise deriv	2014-03-03	2014-03-05	30,967	—	$0	0	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	M Exercise	2014-03-03	2014-03-05	65,806	$9.69	$637.7K	392,537	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	S Sale	2014-03-03	2014-03-05	64,006	$36.72	$2.35M	328,531	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	S Sale	2014-03-03	2014-03-05	1,800	$37.23	$67.0K	326,731	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	M Exercise	2014-03-03	2014-03-05	30,967	$9.69	$300.1K	326,731	SEC↗
MALKIEL BURTON G	Director	G Gift	2014-02-27	2014-05-27	1,000	—	$0	40,000	SEC↗
Aguiar Michael W	Sr VP, Chief Financial Offic	F Tax w/h	2014-02-20	2014-02-24	4,302	$39.98	$172.0K	129,475	SEC↗
BLUM LEONARD M	Sr VP, Chief Comm. Officer	F Tax w/h	2014-02-20	2014-02-24	4,311	$39.98	$172.4K	286,783	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	F Tax w/h	2014-02-20	2014-02-24	3,854	$39.98	$154.1K	148,287	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	F Tax w/h	2014-02-20	2014-02-24	4,307	$39.98	$172.2K	182,316	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	F Tax w/h	2014-02-20	2014-02-24	4,310	$39.98	$172.3K	295,764	SEC↗
Winningham Rick E	Chief Executive Officer	F Tax w/h	2014-02-20	2014-02-24	9,297	$39.98	$371.7K	670,763	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	S Sale	2014-02-14	2014-02-19	30,400	$39.26	$1.19M	191,223	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	S Sale	2014-02-14	2014-02-19	4,600	$40.04	$184.2K	186,623	SEC↗
GLAXOSMITHKLINE PLC	10% Owner	P Buy	2014-02-11	2014-02-13	342,229	$12850698.95	$4397.88B	30,258,302	SEC↗
PASQUALONE FRANK	Sr. Vice President, Operatio	A Award deriv	2014-01-23	2014-01-27	150,000	—	$0	150,000	SEC↗
LEE JUNNING	Sr. VP, Technical Operations	A Award	2014-01-23	2014-01-27	11,000	—	$0	152,141	SEC↗
PASQUALONE FRANK	Sr. Vice President, Operatio	A Award	2014-01-23	2014-01-27	20,000	—	$0	20,000	SEC↗
Aguiar Michael W	Sr VP, Chief Financial Offic	F Tax w/h	2013-11-20	2013-11-22	4,569	$36.40	$166.3K	133,777	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	F Tax w/h	2013-11-20	2013-11-22	4,569	$36.40	$166.3K	222,073	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	F Tax w/h	2013-11-20	2013-11-22	4,569	$36.40	$166.3K	300,074	SEC↗
Winningham Rick E	Chief Executive Officer	F Tax w/h	2013-11-20	2013-11-22	10,046	$36.40	$365.7K	680,060	SEC↗
GLAXOSMITHKLINE PLC	10% Owner	P Buy	2013-10-29	2013-10-29	130,473	$4913613.18	$641.09B	29,916,073	SEC↗
JONKER JEFFREY DAVID	Senior VP, Corp. & Bus. Dev.	A Award deriv	2013-10-22	2013-10-24	150,000	—	$0	150,000	SEC↗
JONKER JEFFREY DAVID	Senior VP, Corp. & Bus. Dev.	A Award	2013-10-22	2013-10-24	15,000	—	$0	15,000	SEC↗
Winningham Rick E	Chief Executive Officer	S Sale	2013-09-12	2013-09-13	22,353	$40.03	$894.8K	690,106	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	M Exercise deriv	2013-08-21	2013-08-22	18,750	—	$0	0	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	M Exercise	2013-08-21	2013-08-22	18,750	$16.00	$300.0K	226,642	SEC↗
Aguiar Michael W	Sr VP, Chief Financial Offic	F Tax w/h	2013-08-20	2013-08-22	4,570	$35.89	$164.0K	138,346	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	F Tax w/h	2013-08-20	2013-08-22	3,813	$35.89	$136.8K	207,892	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	F Tax w/h	2013-08-20	2013-08-22	3,773	$35.89	$135.4K	304,643	SEC↗
Winningham Rick E	Chief Executive Officer	F Tax w/h	2013-08-20	2013-08-22	10,046	$35.89	$360.6K	712,459	SEC↗
GLAXOSMITHKLINE PLC	10% Owner	P Buy	2013-07-30	2013-08-01	3,064,407	$111850855.50	$342756.54B	29,785,600	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	S Sale	2013-07-30	2013-08-01	7,000	$36.51	$255.6K	211,705	SEC↗
Aguiar Michael W	Sr VP, Chief Financial Offic	A Award	2013-07-24	2013-07-26	5,000	—	$0	142,916	SEC↗
BLUM LEONARD M	Sr VP, Chief Comm. Officer	A Award	2013-07-24	2013-07-26	5,000	—	$0	291,094	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	A Award	2013-07-24	2013-07-26	5,000	—	$0	218,705	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	A Award	2013-07-24	2013-07-26	5,000	—	$0	308,416	SEC↗
Winningham Rick E	Chief Executive Officer	A Award	2013-07-24	2013-07-26	11,000	—	$0	722,505	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	S Sale	2013-06-07	2013-06-11	31,038	$35.04	$1.09M	303,416	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	M Exercise deriv	2013-05-29	2013-05-31	6,451	—	$0	0	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	M Exercise deriv	2013-05-29	2013-05-31	4,570	—	$0	0	SEC↗
Brinkley David L	Head of Business Dev.	S Sale	2013-05-29	2013-05-31	3,808	$35.01	$133.3K	48,749	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	M Exercise	2013-05-29	2013-05-31	4,570	$3.10	$14.2K	207,254	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	M Exercise	2013-05-29	2013-05-31	6,451	$12.40	$80.0K	213,705	SEC↗
Aguiar Michael W	Sr VP, Chief Financial Offic	F Tax w/h	2013-05-20	2013-05-22	4,570	$37.01	$169.1K	137,916	SEC↗
BLUM LEONARD M	Sr VP, Chief Comm. Officer	F Tax w/h	2013-05-20	2013-05-22	3,292	$37.01	$121.8K	286,094	SEC↗
Brinkley David L	Head of Business Dev.	F Tax w/h	2013-05-20	2013-05-22	2,443	$37.01	$90.4K	52,557	SEC↗
Mammen Mathai	SVP, Research & Early Clin D	F Tax w/h	2013-05-20	2013-05-22	3,292	$37.01	$121.8K	202,684	SEC↗
Shafer Bradford J	Sr VP, Gen. Counsel, Secreta	F Tax w/h	2013-05-20	2013-05-22	3,292	$37.01	$121.8K	334,454	SEC↗
Winningham Rick E	Chief Executive Officer	F Tax w/h	2013-05-20	2013-05-22	10,046	$37.01	$371.8K	711,505	SEC↗